The database of public procurement
Company
Molecular Devices
Molecular Devices has received 15 EU-wide contract awards from 15 contracting authorities between 2009 and 2023 (as of 2 Oct 2026).
As of: · Source: official notices (Datenservice Öffentlicher Einkauf, CC0), EU Official Journal (TED) and procurement portals · How we count
Awards per year, 2009 to today
Up to 2023 from the EU Official Journal (only contracts above the EU thresholds), from 2024 from the Datenservice Öffentlicher Einkauf and the portals. The current year is incomplete.
Timeline, 36 months
No dated award in the last 36 months.
One dot per award in the month of the notice, sized by value, red when there was only one bid. Click a dot to open the notice.
The network around Molecular
Contracting authorities and neighbours from the award notices, planners from the office register, brands from the bills of quantities of the tender before the award. Figures are lots.
Competitors
No one else in the database wins in these trades with the contracting authorities of this company.
Who wins with the 0 most frequent contracting authorities of this company in the same trades.
References: recently won
No award under this name; the company appears only in bidder lists.
The 0 most recent of 0. All with Pro.
EU-wide awards 2006 to 2023
15 awards from 15 contracting authorities, €2,330,633 stated. The most frequent:
Year, contract, contracting authority, value and bids, each award with its source. See everything with Pro
From the EU Official Journal (TED), matched by company key; subsidiaries are not counted. Listed as “Molecular Devices”, 1.9 bids on average.
Questions and answers
How many public contracts has Molecular Devices won?
The EU Official Journal lists 15 EU-wide awards under this name between 2009 and 2023, from 15 contracting authorities. The notices from 2022 onwards list no award under this name.
Which contracting authorities does Molecular Devices work for most often?
EU-wide between 2009 and 2023, most awards came from Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (1), Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e. V. über Vergabeportal deutsche eVergabe (1) and Friedrich-Loeffler-Institut (1).